Issued Patents 2023
Showing 1–21 of 21 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11814371 | Heterocyclic compound | Guanglong SUN, Chunli Shen, Chengde Wu | 2023-11-14 |
| 11760751 | Benzo 2-azaspiro[4.4]nonane compound and use thereof | Lingyun WU, Peng Yang, Lele ZHAO, Xu YOU, Jian Li | 2023-09-19 |
| 11753377 | Crystal form of 2-methyl-2-propanol and amino-substituted aryl compound | Xiaolin Li, Chong SU, Zhi Luo, Fei Hao, Peng Li +2 more | 2023-09-12 |
| 11739090 | Substituted pyrazlo[3,4-c]pyridines as selective BTK kinase inhibitors | Chunli Shen, Xiawei WEI, Chengde Wu, Guoping HU, Ning JIANG +2 more | 2023-08-29 |
| 11725009 | Anti-influenza virus pyrimidine derivative | Jian Xiong, Chaofeng Long, Jingjing Wang, Xiaoxin Chen, Kevin X. Chen +4 more | 2023-08-15 |
| 11718610 | Compounds containing benzosultam | Xile LIU, Charles Z. Ding, Lihong Hu, Haiwen Wan, Xiu Jiang | 2023-08-08 |
| 11702400 | Salt types, crystal forms, and preparation methods for benzopyrazole compounds as RHO kinase inhibitors | Lingyun WU, Zheming XIAO, Chunyan Jiang, Jian Li | 2023-07-18 |
| 11691974 | 3,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitors | Xiangyu FU, Charles Z. Ding, Lihong Hu, Jianyu LU, Wen Jiang +1 more | 2023-07-04 |
| 11680070 | Thieno[2,3-c]pyridazin-4(1H)-one derivative and application thereof | Xiaoping Zheng, Zhigan Jiang, Haiying He, Jie Li, Zhen Gong +1 more | 2023-06-20 |
| 11680061 | Crystal forms C and E of pyrazin-2(1H)-one compound and preparation method therefor | Fei Hong, Jinming Huang, Longhui Gao, Shicong Wang, Tingting Yin +4 more | 2023-06-20 |
| 11667667 | Steroid derivative FXR agonist | Haiying He, Hualing Xiao, Peng Li, Chunyan Du, Zhi Luo | 2023-06-06 |
| 11655248 | Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor | Yaxian Cai, Zhaobing Xu, Hailong Yang, Shiqi Han, Guoping HU +3 more | 2023-05-23 |
| 11649245 | Cyclopropylamine compound as LSD1 inhibitor and use thereof | Lingyun WU, Qiuyan Wang, Jian Li | 2023-05-16 |
| 11639355 | Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors | Kevin X. Chen, Xiaobing Yan, Jianglei Huang, Yuekun Nie, Guoping HU +3 more | 2023-05-02 |
| 11634424 | Diazaindole derivative and use thereof as CHK1 inhibitor | Yonggang Liao, Wenyuan Qian, Changqing Wei, Yao Xiao, Zhengying Xi +2 more | 2023-04-25 |
| 11623923 | Uracil compound as c-MET/AXL inhibitor | Jinping LI, Xiongbin XU, Gang Li, Lihong Hu, Charles Z. Ding +3 more | 2023-04-11 |
| 11613545 | Macrocyclic compound serving as Wee1 inhibitor and applications thereof | Wenyuan Qian, Chundao Yang, Zhengwei Li, Jie Li, Jian Li | 2023-03-28 |
| 11603366 | Crystalline form and B crystalline form of pyrazine-2(1H)-ketone compound and preparation method thereof | Juan Yu, Fei Hong, Tingting Yin, Zhiliang Chen, Yichao Zhuang +4 more | 2023-03-14 |
| 11597722 | Crystal form D of pyrazine-2(1H)-ketone compound and preparation method therefor | Zhiliang Chen, Zhiyi Luo, Yichao Zhuang, Jinxia Lin, Longhui Gao +4 more | 2023-03-07 |
| 11572372 | Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds | Lifang Wu, Fei Sun, Jinhua DU, Charles Z. Ding, Xiquan Zhang +2 more | 2023-02-07 |
| 11542272 | Five-membered heteroaryl-fused imidazole compound and application thereof | Tao Yu, Lu Gan, Chengde Wu | 2023-01-03 |